From: Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
GOLD II
GOLD III
GOLD IV
No exacerbation
0.73
0.74
0.52
Non-severe exacerbation
0.72
0.51
Severe exacerbation
0.69
0.70
0.49